| Warfarin Sodium Dosages & Strengths | ||||
|---|---|---|---|---|
| Strength | Format | Route | Strength | Class |
| Warfarin Sodium 4 mg | tablet | oral | 1.0 each | OTC |
| Warfarin Sodium 10 mg | tablet | oral | 1.0 each | OTC |
| Warfarin Sodium 1 mg | tablet | oral | 1.0 each | OTC |
| Warfarin Sodium 2 mg | tablet | oral | 1.0 each | OTC |
| Warfarin Sodium 3 mg | tablet | oral | 1.0 each | OTC |
| Warfarin Sodium 5 mg | tablet | oral | 1.0 each | OTC |
| Warfarin Sodium 6 mg | tablet | oral | 1.0 each | OTC |
| Warfarin Sodium 2.5 mg | tablet | oral | 1.0 each | OTC |
| Warfarin Sodium 7.5 mg | tablet | oral | 1.0 each | OTC |
| Warfarin Sodium - | powder | compounding | 100.0 gram(s) | OTC |
Posted by jennyjay about 17 hours ago
Been on coumadin for a year, horrible medication. Have aches all over, legs, shoulders, back, always tired, want to be off th...
Posted by flipper331a 1 day ago
i am an active 63 year old man who had DVT about 6 weeks ago. i run about 10 miles a week and speed walk another 5 miles. als...
Posted by aussiee 5 days ago
I'm a 47yo female & sorry for putting this as a reply to another post - new here:
Gosh.. glad I found this place - have be...
FDA Grants Priority Review for ACIPHEX(R) (rabeprazole sodium ... - Earthtimes
Patients on warfarin (such as Coumadin(R)) may need to be monitored more closely by their doctor. To learn more, talk to your doctor and see the full ...
Fri Feb 29 17:59:23 -0500 2008
China blacklists 141 seriously polluting products - Xinhua
The list included products closely linked to people's daily life, such as warfarin, mirex, DDT and nickel-cadmium cell, said Pan Yue, State Environmental ...
Tue Feb 26 07:20:03 -0500 2008
China blacklists 141 seriously polluting products - People's Daily Online
The list included products closely linked to people's daily life, such as warfarin, mirex, DDT and nickel-cadmium cell, said Pan Yue, State Environmental ...
Tue Feb 26 08:16:05 -0500 2008
warfarin sodium - The sodium salt form of warfarin, a coumarin and a vitamin K antagonist, with anticoagulant activity. Warfarin sodium inhibits both vitamin K and vitamin K epoxide reductases, thereby interfering with the cyclic interconversion of vitamin K epoxide to its reduced form, vitamin KH2. Vitamin KH2 is a cofactor for the carboxylation of glutamate residues on the N-terminal regions of vitamin K-dependent proteins. As a result, maturation of vitamin K-dependent coagulation factors II, VII, IX, and X and anticoagulant proteins C and S is inhibited. Without these coagulation factors, thrombogenesis and blood clot formation are prevented.